Latest News
Abbott secures CE Mark for Cologuard Plus in Europe
20 October 2026 - Abbott Laboratories (NYSE: ABT), a global healthcare company, said on Tuesday that Cologuard Plus has received CE Mark approval under the European Union's In Vitro Diagnostic Medical Devices Regulation, clearing the way for its...
Solventum's combined use of Restrata Matrix and Solventum VAC Therapy receives FDA 510(k) clearance
20 October 2026 - Solventum Corporation (NYSE: SOLV), a US-based company involved in advanced wound healing, announced on Monday that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of Restrata Synthetic El...
West Pharmaceutical declares quarterly dividend
20 October 2026 - West Pharmaceutical Services, Inc. (NYSE: WST), a US-based provider of solutions for injectable drug administration, announced Monday that its board of directors has declared a fourth-quarter dividend of USD0.26 per share on the com...
WuXi AppTec recognised in Frost & Sullivan's Global Company of the Year awards for Tenth Consecutive Year
20 October 2026 - WuXi AppTec Co., Ltd. (SSE: 603259; HKEX: 2359), a China-based global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organisation), said on Monday it has received Frost & Sullivan's 2026 Global Comp...
Sisram Medical s Profhilo registration application receives Chinese regulatotry acceptance for facial indication
20 October 2026 - Sisram Medical Ltd (HKG: 1696), a China-based global wellness group offering Energy-Based Devices (EBDs), injectables, and other complementary solutions, announced on Monday that China's National Medical Products Administration...